Sign In
Buy MDRX
$4.80
-0.200 (-4.00%)
At Close: Jul 31, 2026
Baxter (BAX) to Enhance Its Portfolio With Latest Partnership
03:09pm, Monday, 14'th Mar 2022 Zacks Investment Research
Baxter's (BAX) latest strategic partnership with Digital Diagnostics is expected to expand its connected care diagnostics portfolio.
Here's Why You Should Retain Masimo (MASI) Stock For Now
04:50pm, Friday, 11'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Masimo (MASI) owing to its focus on patient monitoring.
Zacks Investment Ideas feature highlights: Allscripts Healthcare Solutions and Change Healthcare
02:20pm, Friday, 11'th Mar 2022 Zacks Investment Research
Allscripts Healthcare Solutions and Change Healthcare are included in this investment ideas blog.
Medical IT Providers Marching to Their Own Beat
05:30pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Medical IT Providers Marching to Their Own Beat
Reasons to Add Quidel (QDEL) Stock To Your Portfolio Now
03:51pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.
Allscripts (MDRX) Unveils Newly Rebranded App Expo Site
02:15pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Allscripts' (MDRX) rebranded App Expo site to offer developers an opportunity to present their certified solutions online.
Medical IT Providers Marching to Their Own Beat
01:32pm, Thursday, 10'th Mar 2022
Medical IT Providers Marching to Their Own Beat
Allscripts (MDRX) Unveils Newly Rebranded App Expo Site
10:32am, Thursday, 10'th Mar 2022
Allscripts' (MDRX) rebranded App Expo site to offer developers an opportunity to present their certified solutions online.
Reasons to Retain Catalent (CTLT) Stock in Your Portfolio
04:49pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism on the stock.
Nevro's (NVRO) PDN Therapy Gets Noridian's Medicare Coverage
04:09pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
Latest favorable coverage decision for Nevro's (NVRO) PDN Therapy by Noridian is expected to allow the former to serve a wider patient pool.
Is Bayer Aktiengesellschaft (BAYRY) Outperforming Other Medical Stocks This Year?
02:40pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
Here is how Bayer Aktiengesellschaft (BAYRY) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.
Allscripts (MDRX) Inks Divestment Deal to Focus on Core Wing
02:15pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
Constellation Software will purchase the net assets of Allscripts' (MDRX) Hospitals and Large Physician Practices business segment via its wholly-owned subsidiary.
Allscripts (MDRX) Up 4.5% Since Q4 Earnings: What's Driving It?
01:48pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
Allscripts' (MDRX) stock rallies on better-than-expected fourth-quarter performance and recent alliances.
Allscripts (MDRX) Up 4.5% Since Q4 Earnings: What's Driving It?
10:32am, Wednesday, 09'th Mar 2022
Allscripts' (MDRX) stock rallies on better-than-expected fourth-quarter performance and recent alliances.
Allscripts (MDRX) Inks Divestment Deal to Focus on Core Wing
10:32am, Wednesday, 09'th Mar 2022
Constellation Software will purchase the net assets of Allscripts' (MDRX) Hospitals and Large Physician Practices business segment via its wholly-owned subsidiary.
